Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the high-throughput machines ... next-generation sequencing, now with ...

Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...

Illumina is a global leader in developing the tools that help scientists analyze strands of DNA as well as large amounts of complex genetic data through multiomic sequencing. Researchers and ...

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms and make Nvidia’s BioNeMo tools available on the next-gen sequencing ... has to be machine-readable.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology ...

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted ...

Findings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single blood sample ANGLE invited to present data at EACR-Illumina ... DNA dual analysis NGS ...